Correlation between FINDRISC, dyslipidemia and degree of hypothyroidism control in a Latin American health institution
Metabolic disorders
DOI:
https://doi.org/10.69789/cc.v18i1.646Keywords:
Diabetes, hypothyroidism, endocrinopathies, epidemiology, dyslipidemias.Abstract
Thyroid dysfunction and diabetes mellitus are prevalent endocrinopathies with a significant impact on cardiovascular health, and their bidirectional relationship has been widely studied. This retrospective study analyzed 100 patients with hypothyroidism in a South American hospital between January 2020 and December 2023, evaluating their risk of diabetes using the FINDRISC score and correlating it with lipid profiles and the degree of hypothyroidism control. The results showed a high prevalence of dyslipidemia, especially in women, with 67% elevated total cholesterol and 63% elevated triglycerides. A significant correlation was observed between uncontrolled hypothyroidism and FINDRISC moderate and high risk scores. The discussion highlights the importance of better clinical control of lipid alterations and the risk of diabetes in patients with hypothyroidism, since both disorders can increase the risk of cardiovascular complications. The conclusions highlight the need for larger studies to confirm these findings and improve the management of these patients, suggesting that early detection and appropriate management can minimize risks and medical complications.
References
Pérez-Martínez P, Mikhailidis DP, Athyros VG, Bullo M, Couture P, Covas MI, et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. Nutr Rev [Internet]. 2017;75(5):307–26. Disponible en: http://dx.doi.org/10.1093/nutrit/nux014
Wang HH, Lee DK, Liu M, Portincasa P, Wang DQ-H. Novel insights into the pathogenesis and management of the metabolic syndrome. Pediatr Gastroenterol Hepatol Nutr [Internet]. 2020;23(3):189. Disponible en: http://dx.doi.org/10.5223/pghn.2020.23.3.189
Choo J, Yoon S-J, Ryu H, Park M-S, Lee H, Park Y, et al. The Seoul metropolitan lifestyle intervention program and metabolic syndrome risk: A retrospective database study. Int J Environ Res Public Health [Internet]. 2016;13(7):667. Disponible en: http://dx.doi.org/10.3390/ijerph13070667
ter Horst R, van den Munckhof ICL, Schraa K, Aguirre-Gamboa R, Jaeger M, Smeekens SP, et al. Sex-specific regulation of inflammation and metabolic syndrome in obesity. Arterioscler Thromb Vasc Biol [Internet]. 2020;40(7):1787–800. Disponible en: http://dx.doi.org/10.1161/atvbaha.120.314508
Gurka MJ, Golden SH, Musani SK, Sims M, Vishnu A, Guo Y, et al. Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study. Diabetologia [Internet]. 2017;60(7):1261–70. Disponible en: http://dx.doi.org/10.1007/s00125-017-4267-6
Gouveia, É. R., Gouveia, B. R., Marques, A., Peralta, M., França, C., Lima, A., Campos, A., Jurema, J., Kliegel, M., & Ihle, A. (2021). Predictors of Metabolic Syndrome in Adults and Older Adults from Amazonas, Brazil. International journal of environmental research and public health, 18(3), 1303. https://doi.org/10.3390/ijerph18031303
Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic review of metabolic syndrome biomarkers: A panel for early detection, management, and risk stratification in the west Virginian population. Int J Med Sci [Internet]. 2016;13(1):25–38. Disponible en: http://dx.doi.org/10.7150/ijms.13800
Tang K, Zhang Q, Peng N-C, Zhang M, Xu S-J, Li H, et al. Epidemiology of metabolic syndrome and its components in Chinese patients with a range of thyroid-stimulating hormone concentrations. J Int Med Res [Internet]. 2020;48(11):030006052096687. Disponible en: http://dx.doi.org/10.1177/0300060520966878
Shin KA, Kim EJ. Association between thyroid hormone and components of metabolic syndrome in euthyroid Korean adults: A population-based study. Medicine (Baltimore) [Internet]. 2021;100(51):e28409. Disponible en: http://dx.doi.org/10.1097/md.0000000000028409
Tian L, Shao F, Qin Y, Guo Q, Gao C. Hypothyroidism and related diseases: a methodological quality assessment of meta-analysis. BMJ Open [Internet]. 2019;9(3):e024111. Disponible en: http://dx.doi.org/10.1136/bmjopen-2018-024111
Kim HK, Song J. Hypothyroidism and diabetes-related dementia: Focused on neuronal dysfunction, insulin resistance, and dyslipidemia. Int J Mol Sci [Internet]. 2022;23(6):2982. Disponible en: http://dx.doi.org/10.3390/ijms23062982
Liu F-H, Hwang J-S, Kuo C-F, Ko Y-S, Chen S-T, Lin J-D. Subclinical hypothyroidism and metabolic risk factors association: A health examination-based study in northern Taiwan. Biomed J [Internet]. 2018;41(1):52–8. Disponible en: http://dx.doi.org/10.1016/j.bj.2018.02.002
Liu H, Peng D. Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism. Endocr Connect. 2022 Feb 7;11(2):e210002. doi: 10.1530/EC-21-0002.
Jølle A, Midthjell K, Holmen J, Carlsen SM, Tuomilehto J, Bjørngaard JH, et al. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study. BMJ Open Diabetes Res Care [Internet]. 2019;7(1):e000769. Disponible en: http://dx.doi.org/10.1136/bmjdrc-2019-000769
Gomez-Arbelaez D, Alvarado-Jurado L, Ayala-Castillo M, et al.. Evaluation of the Finnish diabetes risk score to predict type 2 diabetes mellitus in a Colombian population: a longitudinal observational study. World J Diabetes 2015;6:1337–44. 10.4239/wjd.v6.i17.1337
Dong X, Yao Z, Hu Y, Yang N, Gao X, Xu Y, et al. Potential harmful correlation between homocysteine and low-density lipoprotein cholesterol in patients with hypothyroidism. Medicine (Baltimore) 2016;95(29):e4291. http://doi.org/10.1097/MD.0000000000004291.
Teixeira P de F dos S, dos Santos PB, Pazos-Moura CC. The role of thyroid hormone in metabolism and metabolic syndrome. Ther Adv Endocrinol Metab [Internet]. 2020;11:204201882091786. Disponible en: http://dx.doi.org/10.1177/2042018820917869
Raposo L, Martins S, Ferreira D, Guimarães JT, Santos AC. Metabolic syndrome, thyroid function and autoimmunity - the PORMETS study. Endocr Metab Immune Disord Drug Targets [Internet]. 2019;19(1):75–83. Disponible en: http://dx.doi.org/10.2174/1871530318666180801125258
Li R-C, Zhang L, Luo H, Lei Y, Zeng L, Zhu J, et al. Subclinical hypothyroidism and anxiety may contribute to metabolic syndrome in Sichuan of China: a hospital-based population study. Sci Rep [Internet]. 2020;10(1). Disponible en: http://dx.doi.org/10.1038/s41598-020-58973-w
Bermúdez V, Salazar J, Añez R, Rojas M, Estrella V, Ordoñez M, et al. Metabolic Syndrome and subclinical hypothyroidism: A type 2 diabetes-dependent association. J Thyroid Res [Internet]. 2018;2018:1–8. Disponible en: http://dx.doi.org/10.1155/2018/8251076
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Jorge Andrés Hernández Navas, Luis Dulcey-Sarmiento, Juan Therán-León, Jaime Gómez-Ayala, Valentina Ochoa-Castellanos, Diana Villamizar-Olarte, Valentina Castañeda-Otálora, Jerson Quitian-Moreno, Harold Torres-Pinzón, Laura Esteban-Badillo
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los artículos de Crea Ciencia están publicados en acceso abierto bajo una licencia CC BY-NC-SA 4.0 de la Universidad Evangélica de El Salvador.
